Panel Academic Debates track
Academic Debate: Is Resmetirom or Semaglutide the Best First-Line Treatment for Metabolic Dysfunction–Associated Steatohepatitis With Stage 2–3 Fibrosis?
Fri, Nov 6, 2026 · 9:45–10:45 AM MST Convention Center: Bluebird Ballroom 1C, Colorado Convention Center
About this session
Explore timely topics in liver disease in a lively debate format as hepatology trainees and practicing hepatologists tackle important often controversial issues. Debaters gain skills in critical thinking, balanced argumentation, and factual examination of each issue’s pros and cons. Debaters, judges, and audience members grapple with opposing scientific, societal, individual, and financial viewpoints on current clinical concerns.
Speakers
Reviews of this session
No reviews yet
Were you in the room? Reviews are open until Nov 9, 2027.